Home » North Dakota

North Dakota

North Dakota hopes to double the $3B of clean crypto mining in the state

North Dakota government officials rocked up to the Bitcoin 2022 conference in Miami to lure cryptocurrency miners into their greener pastures. They came with the promise of the “cleanest crypto on the planet.” The North Dakota Commerce Department dropped $35,000 on the trip, saying it expected a return of 20,000% or more from its presence at the conference. The department announced that the state has already secured $3 billion of crypto investment and is close to attracting another $3 billion worth of projects. North Dakota hopes to end its reliance on agriculture and oil by enticing crypto mining companies to set up in the Upper Midwest state. There are no tax breaks or funding as the state is relying on its natural assets. It’s known for cold, dry weather which can help chill out overhea...

US election: Republicans hold back Democrats, narrowing path to Senate control

The battle for power in the Senate tightened into Wednesday as Democrats picked up a seat in Colorado, but suffered a setback in Alabama, and Republicans held their own in high-profile races in South Carolina, Iowa, Texas and Kansas, dramatically narrowing the political map. Republicans fought to retain their Senate majority by turning back a surge of Democrats challenging allies of President Donald Trump, and the Democrats’ various paths to seizing control were growing more limited. With several contests still too early to call, and one Georgia race heading to a January runoff, the final verdict is expected to drag on. Democrats gained a seat when ex-Gov. John Hickenlooper ousted GOP Sen. Cory Gardner in Colorado, a must-win to flip the Senate, but couldn’t hold on in Alabama, where forme...

Gold rises on renewed US stimulus hope, dollar falls

Spot gold rose 0.3 percent to $1,910.56 an ounce at 3:37pm, New York time, after falling as much as 0.5 percent. Gold rose on renewed optimism for a preelection aid package in the U.S., while the dollar fell to a one-week low. House Speaker Nancy Pelosi said a bill for a compromise stimulus package is being written as she awaits a key phone call with Treasury Secretary Steven Mnuchin. Senate Majority Leader Mitch McConnell said his chamber would take up a comprehensive coronavirus package if an accord is struck. The Bloomberg Dollar Spot Index headed for the third straight decline. Pelosi said in a Bloomberg Television interview that while there are areas where more work is required to get a compromise, she was pleased with the Trump administration’s latest position on coronavirus testing ...

Ransomware reportedly to blame for outage at US hospital chain

Health care provider Universal Health Services, one of the largest chains in the US, has been hit by an apparent ransomware attack, TechCrunch reported. UHS facilities in California, Florida, North Dakota, Arizona, and other locations began noticing problems early Sunday, with some locations reporting locked computers and phone systems. Some UHS hospitals had to use pen and paper to file patient information as a result, according to NBC News. The hospital system, which has more than 400 locations in the US and the UK, said in a statement on Monday that its IT network across several facilities was offline “due to an IT security issue.” No patient or employee data appears to have been compromised, according to the statement, which did not mention malware or ransomware. “We implement extensiv...

Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine

Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...